Skip to main content
. 2016 Jun 24;6(2):411–422. doi: 10.5500/wjt.v6.i2.411

Table 4.

Area under the curves and 95%CI for the Milan, University of California, San Francisco, and National Cancer Center Korea criteria for the prediction of 1, 3, and 5 years disease-free survival

Diagnostic approach Criteria AUC (95%CI)
1 yr 3 yr 5 yr
Preoperative Milan1 0.814 0.804 0.799
imaging (0.754, 0.873) (0.750, 0.858) (0.747, 0.851)
UCSF2 0.812 0.800 0.793
(0.754, 0.871) (0.747, 0.853) (0.741, 0.844)
NCCK3 0.810 0.806 0.802
(0.753, 0.867) (0.755, 0.857) (0.753, 0.852)
Explant pathology Milan4 0.824 0.815 0.807
(0.767, 0.880) (0.764, 0.866) (0.757, 0.856)
UCSF5 0.819 0.811 0.803
(0.761, 0.877) (0.759, 0.863) (0.752, 0.853)
NCCK6 0.823 0.817 0.810
(0.769, 0.878) (0.767, 0.866) (0.762, 0.857)
1

Adjusted by PET, X, Y and Z;

2

By PET, X and Y;

3

By maximum tumor size, X, Y, and Z;

4

By PET, total tumor size, X and Y;

5

By PET, X, Y, and Z;

6

By total tumor size, X, Y, and Z. X: Microvascular invasion; Y: Major vessel invasion; Z: Intrahepatic metastasis; AUC: Area under the curves; UCSF: University of California, San Francisco; PET: Positron emission tomography; NCCK: National Cancer Center Korea; 95%CI and P value were calculated by Cox PH regression analyses adjusted by the following covariates for each criteria.